MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Global Parkinson’s Genetics Program (GP2) Underrepresented Populations Working Group

AF. Schumacher-Schuh, S-Y. Lim, O. Okunoye, S. Bandres-Ciga, P. Heutink, H. Iwaki, R. Kruger, K. Mok, A. Noyce, NU. Okubadejo, M. Rizig, R. Rajan, LK. Prashanth, M. Sharma, J. Shulman, B. Siddiqi, S. Bardien, IF. Mata, GP2. Genetics Project (Porto Alegre, Brazil)

Meeting: MDS Virtual Congress 2021

Abstract Number: 751

Keywords: Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: GP2’s Underrepresented Populations Working Group (WG) was created for individuals working within underrepresented/underserved populations to join forces to increase global representation and decipher the genetic factors associated with Parkinson’s disease (PD) in non-European populations.

Background: The Global Parkinson’s Genetics Program (GP2) is an ambitious project that aims to provide an exceptional understanding of the genetic architecture of PD. The lack of diversity in published genetic studies is a critical challenge to overcome, and therefore one of GP2’s primary goals is to recruit at least 50,000 participants from underrepresented/underserved populations worldwide over the next 5 years.

Method: Our WG comprises clinicians and researchers from different regions, including Latin America, Africa, India and East Asia. We hold fortnightly meetings to share ideas and needs and align our goals. Our work includes recruiting people with PD, including large families, and ethnically matched healthy controls from underrepresented/underserved populations. We are also working closely with other GP2 WGs such as the Complex Disease Data Analysis WG to develop the analytical tools necessary to deal with our different and complex genetic admixture.

Results: Strategies for collaborative data upload, access, and analysis are making it possible to perform projects such as a trans-ethnic meta-analysis and fine-mapping, involving a diversity of researchers, resources, and data from Latin American, African, Asian, and European populations. Another essential part of our mission is to support the development of sustainable local clinical and analytical expertise by providing resources such as training opportunities for local researchers, facilitated by close collaboration with GP2’s Training WG and GP2‐supported cloud computing enabling complex analysis in areas with limited access to computing resources.

Conclusion: We envision a future where  diverse collaboration, together with democratizing data, leads to a better understanding of PD genetics among communities currently underserved in research while empowering local researchers.

To cite this abstract in AMA style:

AF. Schumacher-Schuh, S-Y. Lim, O. Okunoye, S. Bandres-Ciga, P. Heutink, H. Iwaki, R. Kruger, K. Mok, A. Noyce, NU. Okubadejo, M. Rizig, R. Rajan, LK. Prashanth, M. Sharma, J. Shulman, B. Siddiqi, S. Bardien, IF. Mata, GP2. Genetics Project. The Global Parkinson’s Genetics Program (GP2) Underrepresented Populations Working Group [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/the-global-parkinsons-genetics-program-gp2-underrepresented-populations-working-group/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-global-parkinsons-genetics-program-gp2-underrepresented-populations-working-group/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley